Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
JMDC Inc. ( (JP:4483) ) has shared an update.
JMDC Inc. reported a significant increase in its financial performance for the first half of the fiscal year ending March 31, 2026, with a 24.4% rise in revenue and a 27.7% increase in operating profit compared to the previous year. The company’s strategic decision to classify its dispensing pharmacy support business as discontinued operations has streamlined its focus on core operations, potentially strengthening its market position and benefiting stakeholders.
The most recent analyst rating on (JP:4483) stock is a Buy with a Yen5500.00 price target. To see the full list of analyst forecasts on JMDC Inc. stock, see the JP:4483 Stock Forecast page.
More about JMDC Inc.
JMDC Inc. operates in the healthcare industry and is listed on the Tokyo Stock Exchange. The company focuses on providing data-driven healthcare solutions, including analytics and support services, to enhance medical and pharmaceutical operations.
Average Trading Volume: 296,956
Technical Sentiment Signal: Buy
Current Market Cap: Yen319.8B
See more insights into 4483 stock on TipRanks’ Stock Analysis page.